Stealth BioTherapeutics Corp. ADS (MITO)

Data is currently not available

Quotes

NEWS & ANALYSIS

MITO MITO PRESS RELEASES

MITO Press Releases

Published
Apr 6, 2021

Stealth BioTherapeutics Reports Fiscal Year 2020 Financial Results And Recent Business Highlights

Published
Apr 6, 2021
Published
Mar 31, 2021

Stealth BioTherapeutics to Report Full Year 2020 Financial Results on Tuesday, April 6, 2021

Published
Mar 31, 2021
Published
Mar 16, 2021

Stealth BioTherapeutics Announces Promotion of Marty Redmon to Chief Research & Development Officer

Published
Mar 16, 2021
Published
Mar 2, 2021

Stealth BioTherapeutics to Present at Upcoming Investor Conferences in March

Published
Mar 2, 2021
Published
Feb 23, 2021

Stealth BioTherapeutics Completes Enrollment of Phase 2 Study in Dry Age-Related Macular Degeneration with Geographic Atrophy

Published
Feb 23, 2021
Published
Feb 10, 2021

Stealth BioTherapeutics Announces Pricing Of $4.7 Million Registered Direct Offering Of American Depositary Shares

Published
Feb 10, 2021
Published
Jan 7, 2021

Stealth BioTherapeutics to Participate in Upcoming January Investor Conferences

Published
Jan 7, 2021
Published
Jan 5, 2021

Stealth BioTherapeutics Granted Pre-NDA Meeting For Elamipretide As A Treatment For Cardiomyopathy In Barth Syndrome

Published
Jan 5, 2021
Published
Dec 9, 2020

Stealth BioTherapeutics Announces Elamipretide Clinical Data to be Presented at the 13th International Conference on Cachexia, Sarcopenia and Wasting Diseases

Published
Dec 9, 2020
Published
Dec 7, 2020

Stealth BioTherapeutics Announces Appointment of Eve E. Slater, M.D., F.A.C.C. to its Board of Directors

Published
Dec 7, 2020
Published
Nov 24, 2020

Stealth BioTherapeutics Announces Closing of $3.2 Million Registered Direct Offering

Published
Nov 24, 2020
Published
Nov 20, 2020

Stealth BioTherapeutics Announces $3.2 Million Registered Direct Offering

Published
Nov 20, 2020
Published
Nov 5, 2020

Stealth BioTherapeutics Reports Third Quarter 2020 Financial Results And Recent Business Highlights

Published
Nov 5, 2020
Published
Nov 4, 2020

Stealth BioTherapeutics Announces Development Financing To Advance Elamipretide Clinical Trials

Published
Nov 4, 2020
Published
Oct 30, 2020

Stealth BioTherapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020

Published
Oct 30, 2020
Published
Oct 19, 2020

Stealth BioTherapeutics Announces Poster Presentation at American Society of Human Genetics (ASHG) Virtual Annual Meeting

Published
Oct 19, 2020
Published
Sep 23, 2020

Stealth BioTherapeutics Announces Poster Presentation at 2020 Annual NEALS Meeting

Published
Sep 23, 2020
Published
Sep 10, 2020

Stealth BioTherapeutics to Present at Upcoming Investor Conferences in September

Published
Sep 10, 2020
Published
Aug 6, 2020

Stealth BioTherapeutics Reports Second Quarter 2020 Financial Results and Recent Business Highlights

Published
Aug 6, 2020
Published
Jul 30, 2020

Stealth BioTherapeutics to Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020

Published
Jul 30, 2020
Back to MITO Overview

Related Symbols

GME

Data is currently not available
AAPL

Data is currently not available
TSLA

Data is currently not available
AMC

Data is currently not available